Vik Chopra
Stock Analyst at Wells Fargo
(3.83)
# 956
Out of 5,182 analysts
68
Total ratings
55.17%
Success rate
10.55%
Average return
Main Sectors:
Stocks Rated by Vik Chopra
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SOLV Solventum | Maintains: Equal-Weight | $86 → $83 | $69.78 | +18.95% | 6 | Feb 27, 2026 | |
| IART Integra LifeSciences Holdings | Maintains: Equal-Weight | $13 → $12 | $10.69 | +12.25% | 3 | Feb 27, 2026 | |
| XRAY DENTSPLY SIRONA | Maintains: Equal-Weight | $12 → $13 | $11.96 | +8.70% | 5 | Feb 27, 2026 | |
| GMED Globus Medical | Maintains: Overweight | $98 → $104 | $93.70 | +10.99% | 12 | Feb 26, 2026 | |
| HSIC Henry Schein | Maintains: Equal-Weight | $76 → $87 | $77.20 | +12.69% | 4 | Feb 25, 2026 | |
| MASI Masimo | Downgrades: Equal-Weight | $190 → $180 | $178.66 | +0.75% | 11 | Feb 18, 2026 | |
| NVST Envista Holdings | Maintains: Equal-Weight | $21 → $26 | $26.77 | -2.88% | 4 | Feb 6, 2026 | |
| ALGN Align Technology | Maintains: Overweight | $181 → $200 | $184.70 | +8.28% | 5 | Feb 5, 2026 | |
| CNMD CONMED | Maintains: Equal-Weight | $41 → $42 | $37.87 | +10.91% | 7 | Jan 29, 2026 | |
| ENOV Enovis | Maintains: Overweight | $41 → $42 | $24.54 | +71.15% | 5 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $16 | $17.25 | -7.25% | 4 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $16 | $10.36 | +54.44% | 2 | Oct 16, 2025 |
Solventum
Feb 27, 2026
Maintains: Equal-Weight
Price Target: $86 → $83
Current: $69.78
Upside: +18.95%
Integra LifeSciences Holdings
Feb 27, 2026
Maintains: Equal-Weight
Price Target: $13 → $12
Current: $10.69
Upside: +12.25%
DENTSPLY SIRONA
Feb 27, 2026
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $11.96
Upside: +8.70%
Globus Medical
Feb 26, 2026
Maintains: Overweight
Price Target: $98 → $104
Current: $93.70
Upside: +10.99%
Henry Schein
Feb 25, 2026
Maintains: Equal-Weight
Price Target: $76 → $87
Current: $77.20
Upside: +12.69%
Masimo
Feb 18, 2026
Downgrades: Equal-Weight
Price Target: $190 → $180
Current: $178.66
Upside: +0.75%
Envista Holdings
Feb 6, 2026
Maintains: Equal-Weight
Price Target: $21 → $26
Current: $26.77
Upside: -2.88%
Align Technology
Feb 5, 2026
Maintains: Overweight
Price Target: $181 → $200
Current: $184.70
Upside: +8.28%
CONMED
Jan 29, 2026
Maintains: Equal-Weight
Price Target: $41 → $42
Current: $37.87
Upside: +10.91%
Enovis
Nov 7, 2025
Maintains: Overweight
Price Target: $41 → $42
Current: $24.54
Upside: +71.15%
Nov 5, 2025
Maintains: Overweight
Price Target: $15 → $16
Current: $17.25
Upside: -7.25%
Oct 16, 2025
Maintains: Overweight
Price Target: $14 → $16
Current: $10.36
Upside: +54.44%